The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|11|1512-1518

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.11, 2012-04, pp. : 1512-1518

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B Cell-Targeted Therapy for Rheumatoid Arthritis: An Update on the Evidence

By Looney R. John  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 625-639

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite

A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients

By Fu Bo   Lunt Mark   Galloway James   Dixon Will   Hyrich Kimme   Symmons Deborah  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 2, 2013-03 ,pp. : 461-476

Taylor & Francis Ltd

Access to resources Recommend Favorite

The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis

By Bar-Yehuda Sara   Silverman Michael H   Kerns William D   Ochaion Avivit   Cohen Shira   Fishman Pnina  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1601-1613

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances for Cell / Gene Therapy in Rheumatoid Arthritis

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 2, 2004-06 ,pp. : 119-138

Bentham Science Publishers

Access to resources Recommend Favorite